Correction

Cardiovascular risk of gonadotropin-releasing hormone antagonist versus agonist in men with prostate cancer: an observational study in Taiwan (Jun, 10.1038/s41391-022-00555-0, 2022)

PROSTATE CANCER AND PROSTATIC DISEASES (2023)

Get Full Text
Add to Collection

Journal

PROSTATE CANCER AND PROSTATIC DISEASES
Volume 26, Issue 3, Pages 633-634

Publisher

SPRINGERNATURE
DOI: 10.1038/s41391-022-00596-5

Keywords

-

Categories

Oncology Urology & Nephrology

Ask authors/readers for more resources

Protocol

Community support

Reagent

Community support

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Recommended

No Data Available
No Data Available
Webinars Posters Questions Hubs Funding Journals Papers Connect Collections Reviewers About Us FAQs Mobile App Privacy Policy Terms of Use
© Peeref 2019-2024. All rights reserved.